6. Goodwill and Indefinite-Lived Intangible Assets (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
Oct. 31, 2019 |
|
| Indefinite-lived Intangible Assets [Line Items] | |||
| Carrying value of indefinite-lived intangible asset | $ 9,243,128 | $ 9,243,128 | |
| Impairment of indefinite-lived intangible asset | 0 | 0 | |
| Serum Institute of India Ltd [Member] | |||
| Indefinite-lived Intangible Assets [Line Items] | |||
| Prepaid clinical supply | 700,000 | 700,000 | |
| Pharmsynthez Loan [Member] | |||
| Indefinite-lived Intangible Assets [Line Items] | |||
| Note receivable face amount | $ 500,000 | ||
| Note receivable interest rate | 10.00% | ||
| Interest income | 9,000 | ||
| OncoHist [Member] | |||
| Indefinite-lived Intangible Assets [Line Items] | |||
| Carrying value of indefinite-lived intangible asset | 9,200,000 | 9,200,000 | |
| Impairment of indefinite-lived intangible asset | $ 0 | $ 0 | |
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest and fee income from loans classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Note receivable face amount No definition available.
|
| X | ||||||||||
- Definition Note receivable interest rate No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|